Science ❯ Biotechnology ❯ Research and Development
Drug Approval Phase I Trials Cancer Research Covid-19 Treatments Innovative Therapies Cancer Stem Cells Phase 2 Trials Oncology
A 38-for-1 split in mid-June sparked massive trading in its thinly floated shares.
